Hennion & Walsh Asset Management’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-48,769
Closed -$733K 935
2025
Q1
$733K Sell
48,769
-11,240
-19% -$166K 0.03% 550
2024
Q4
$865K Sell
60,009
-1,115
-2% -$19.9K 0.04% 498
2024
Q3
$1.19M Sell
61,124
-763
-1% -$13.8K 0.06% 408
2024
Q2
$1.06M Buy
61,887
+4,877
+9% +$90K 0.05% 408
2024
Q1
$958K Buy
57,010
+1,388
+2% +$21.1K 0.05% 431
2023
Q4
$1.01M Buy
55,622
+3,887
+8% +$70.7K 0.06% 404
2023
Q3
$876K Buy
51,735
+24,437
+90% +$350K 0.06% 389
2023
Q2
$328K Buy
+27,298
New +$372K 0.02% 627
2021
Q2
Sell
-33,878
Closed -$957K 735
2021
Q1
$957K Buy
+33,878
New +$1.08M 0.06% 363

Other funds holding HCM

Hennion & Walsh Asset Management's HCM Position: Q2 2025 in Review

Hennion & Walsh Asset Management sold out of HUTCHMED (HCM) in Q2 2025, closing a stake of 48,769 shares — an estimated $733K sold.

Hennion & Walsh Asset Management first reported a position in HCM in Q1 2021 and held it in 9 quarters. The position peaked at $1.19M in Q3 2024. 63 funds tracked by Wall St. Rank hold HCM as of Q2 2025.

  • Hennion & Walsh Asset Management reported no remaining HUTCHMED position as of Q2 2025 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 48,769 HUTCHMED shares in Q2 2025, an estimated $733K.
  • Hennion & Walsh Asset Management first reported a position in HUTCHMED in Q1 2021 and held it in 9 quarters.
  • Hennion & Walsh Asset Management's HUTCHMED position peaked at $1.19M in Q3 2024.
  • 63 funds tracked by Wall St. Rank held HUTCHMED as of Q2 2025.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.